01 April 2020
: Case report
Successful Management of the First Case of a Metastasized Complete Mole in Form of Twin Pregnancy in Jordan
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Rare disease, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathology
Amer Sindiani1ABCDEF*, Basil Obeidat1ABCD, Eman Alshdaifat2DEFDOI: 10.12659/AJCR.923395
Am J Case Rep 2020; 21:e923395
Abstract
BACKGROUND: A complete mole with a living fetus in a form of twin pregnancy that is a rare obstetric event. The development of metastatic gestational trophoblastic disease is the most important and serious complication. It is debatable whether to terminate the pregnancy or to continue. Another point is the validity of the conservative treatment of this type of neoplasm, especially in developing countries.
CASE REPORT: In this study, we report the first case of a twin pregnancy with complete mole and a living fetus in Jordan, which is a developing country. A 33-year-old woman presented with vaginal bleeding which was revealed to be due to a complete mole in the form of a twin pregnancy. A hystrostomy was performed with subsequent drop of β-hCG level. However, the β-hCG started to rise and the CT scan revealed multiple metastatic sites. Accordingly, she received 3 cycles of methotrexate, with a subsequent reduction in β-hCG level.
CONCLUSIONS: This is the first case report of a complete mole in twin pregnancy in Jordan. To overcome the development of metastasis, close follow-up and immediate treatment are crucial when the conservative approach is being considered. This report highlights the importance of considering the diagnosis of complete mole for women with twin and vaginal bleeding.
Keywords: gestational trophoblastic disease, Hydatidiform Mole, Twins, Antimetabolites, Antineoplastic, Combined Modality Therapy, Hysterotomy, Jordan, Methotrexate, Pregnancy, Pregnancy, Twin, Uterine Hemorrhage, Uterine Neoplasms
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946839
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946674
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945853
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947512
Most Viewed Current Articles
21 Jun 2024 : Case report
96,276
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,197
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
31,128
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,383
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030